Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testagen™ TDS®-Testosterone Transference Study
NCT02733133Phase 2Not yet recruiting
- Sponsor
- Transdermal Delivery Solutions Corporation
- Start
- Jan 2027
- Primary completion
- Oct 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Testosterone TEPI patch in hypogonadotropic hypogonadism (HH), sponsored by Transdermal Delivery Solutions Corporation. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
Testosterone TEPI patch
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT02733133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733133.